Ahmadian E, et al. Covid-19 and kidney injury: pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31: e2176.

Article  CAS  PubMed  Google Scholar 

Ahn SM, et al. Incidence of rheumatic diseases during the COVID-19 pandemic in South Korea. Korean J Intern Med. 2023;38:248–53.

Article  PubMed  PubMed Central  Google Scholar 

Alberts R, et al. Integration and reanalysis of four RNA-Seq datasets including BALF, nasopharyngeal swabs, lung biopsy, and mouse models reveals common immune features of COVID-19. Immune Network. 2022;22: e22.

Article  PubMed  PubMed Central  Google Scholar 

Andreoli L, et al. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 2017;76:476–85.

Article  CAS  PubMed  Google Scholar 

Arkatkar T, et al. B cell-derived IL-6 initiates spontaneous germinal center formation during systemic autoimmunity. J Exp Med. 2017;214:3207–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bader GD, Hogue CW. An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinform. 2003;4:2.

Article  Google Scholar 

Barrett T, et al. NCBI GEO: archive for functional genomics data sets–10 years on. Nucleic Acids Res. 2011;39:D1005-1010.

Article  CAS  PubMed  Google Scholar 

Bastard P, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science (New York, NY). 2020; 370.

Benucci M, et al. Cardiovascular safety, cancer and Jak-inhibitors: Differences to be highlighted. Pharmacol Res. 2022;183: 106359.

Article  CAS  PubMed  Google Scholar 

Bonometti R, et al. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection. Eur Rev Med Pharmacol Sci. 2020;24:9695–7.

CAS  PubMed  Google Scholar 

Bournia VK, et al. Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study. Rheumatology (oxford). 2023;62:1047–56.

Article  PubMed  Google Scholar 

Bronte V, et al. Baricitinib restrains the immune dysregulation in patients with severe COVID-19. J Clin Investig. 2020;130:6409–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bruchelt G, Treuner J, Schmidt K. Proposal for the use of an inhalation drug containing 2–5 oligoadenylates for treatment of COVID-19. Med Hypotheses. 2022;168: 110969.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bruera S et al. Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus. Lupus Sci Med. 2023; 10.

Buszko M, et al. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol. 2021;22:404–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caielli S, et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell. 2021;184:4464-4479.e4419.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Casey KA, et al. Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus. Arthritis Rheumatol (hoboken, NJ). 2021;73:459–71.

Article  CAS  Google Scholar 

Chen T, Liu Y-X, Huang L. ImageGP: an easy-to-use data visualization web server for scientific researchers. iMeta. 2022;1: e5.

Article  Google Scholar 

Cheong JG, et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell. 2023;186:3882-3902.e3824.

Article  CAS  PubMed  Google Scholar 

Chung MW, Komorowski RA, Varma RR. Suloctidil-induced hepatotoxicity. Gastroenterology. 1988;95:490–1.

Article  CAS  PubMed  Google Scholar 

Cordtz R et al. Incidence of COVID-19 hospitalisation in patients with systemic lupus erythematosus: a nationwide cohort study from Denmark. J Clin Med. 2021; 10.

Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023;82:999–1014.

Article  CAS  PubMed  Google Scholar 

da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.

Article  CAS  PubMed  Google Scholar 

Ding X, Xiang W, He X. IFN-I mediates dysfunction of endothelial progenitor cells in atherosclerosis of systemic lupus erythematosus. Front Immunol. 2020;11: 581385.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dougherty J. Hypoglycemic stupor caused by acetohexamide. N Engl J Med. 1966;274:1256–7.

Article  CAS  PubMed  Google Scholar 

Durcan L, Petri M. Immunomodulators in SLE: clinical evidence and immunologic actions. J Autoimmun. 2016;74:73–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fagbemi O, Kane KA, McDonald FM, Parratt JR, Rothaul AL. The effects of verapamil, prenylamine, flunarizine and cinnarizine on coronary artery occlusion-induced arrhythmias in anaesthetized rats. Br J Pharmacol. 1984;83:299–304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT. Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis. 2021;80:14–25.

Article  PubMed  Google Scholar 

Fanouriakis A, et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Ann Rheum Dis. 2024;83:15–29.

Article  CAS  PubMed  Google Scholar 

Farge D, et al. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. Lancet Oncol. 2022;23:e334–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandez-Ruiz R, Niewold TB. Type I interferons in autoimmunity. J Invest Dermatol. 2022;142:793–803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res J Lab Clin Med. 2021;232:13–36.

CAS  Google Scholar 

Ferri C, et al. COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series. Clin Rheumatol. 2020;39:3195–204.

Article  PubMed  PubMed Central  Google Scholar 

Franz M, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60-w64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao F, Tan Y, Luo H. MALAT1 is involved in type I IFNs-mediated systemic lupus erythematosus by up-regulating OAS2, OAS3, and OASL. Braz J Md Biol Res Revista Brasileira De Pesquisas Medicas e Biologicas. 2020;53: e9292.

CAS